Alzamend Neuro Stock Quote ALZN - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.4598

Bid

0.402

Ask

0.46

Volume

148,820

0.413 Day's Range 0.469

0.3691 52 Week Range 8.10

Market Cap

2.684M

Previous Close

0.3909

Open

0.42

Last Trade

0.4502

Last Trade Time

17:30:56

Financial Volume

$ 65,325

VWAP

0.438956

Average Volume (3m)

84,070

Shares Outstanding

6,866,846

Dividend Yield

PE Ratio

-0.21

Earnings Per Share (EPS)

-2.17

Revenue

Net Profit

-14.88M

Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipe... Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.alzamend.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Alzamend Neuro Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALZN. The last closing price for Alzamend Neuro was $0.39. Over the last year, Alzamend Neuro shares have traded in a share price range of $ 0.3691 to $ 8.10.

Alzamend Neuro currently has 6,866,846 shares outstanding. The market capitalization of Alzamend Neuro is $2.68 million. Alzamend Neuro has a price to earnings ratio (PE ratio) of -0.21.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0688	17.5959079284	0.391	0.469	0.3707	44429	0.39493466	CS
4	-0.1102	-19.3333333333	0.57	0.578	0.3691	108445	0.47351004	CS
12	-0.3964	-46.2975940201	0.8562	0.8801	0.3691	84070	0.55448995	CS
26	-0.4902	-51.6	0.95	1.29	0.3691	67180	0.75018687	CS
52	-7.0552	-93.8815701929	7.515	8.1	0.3691	136439	2.61962571	CS
156	-90.4402	-99.4941694169	90.9	124.2	0.3691	1120036	36.832213	CS
260	-434.5402	-99.8942988506	435	503.25	0.3691	1150882	41.78104148	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SVMHSRIVARU Holding Ltd	$ 0.2386 (25.58%)	6.32M
ZAPPZapp Electric Vehicles Group Ltd	$ 11.37 (23.05%)	7.72M
BEEMBeam Global	$ 7.75 (19.41%)	526.86k
SBETSharpLink Gaming Inc	$ 0.6049 (15.88%)	31.98k
NUWENewellis Inc	$ 4.60 (15.58%)	275.16k
SHPWShapeways Holdings Inc	$ 0.405 (-16.94%)	1.56M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.6101 (-14.36%)	749.73k
CONNConns Inc	$ 0.5879 (-11.25%)	24.27k
CAUDCollective Audience Inc	$ 0.4828 (-9.38%)	1.7k
QLGNQualigen Therapeutics Inc	$ 0.255 (-8.90%)	93.8k
MAXNMaxeon Solar Technologies Ltd	$ 0.26 (-3.70%)	10.91M
ZAPPZapp Electric Vehicles Group Ltd	$ 11.37 (23.05%)	7.72M
SVMHSRIVARU Holding Ltd	$ 0.2386 (25.58%)	6.32M
ASTIAscent Solar Technologies Inc	$ 0.1149 (-2.21%)	4.2M
PRTGPortage Biotech Inc	$ 0.1591 (7.50%)	2.7M